STAAR Surgical (NASDAQ:STAA) CTO Keith Holliday sold 2,188 shares of STAAR Surgical stock in a transaction on Thursday, March 22nd. The stock was sold at an average price of $16.03, for a total value of $35,073.64. Following the completion of the sale, the chief technology officer now directly owns 43,781 shares of the company’s stock, valued at approximately $701,809.43. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Keith Holliday also recently made the following trade(s):
- On Tuesday, March 20th, Keith Holliday sold 1,458 shares of STAAR Surgical stock. The stock was sold at an average price of $16.05, for a total value of $23,400.90.
Shares of STAA stock opened at $15.55 on Friday. The company has a quick ratio of 2.13, a current ratio of 2.82 and a debt-to-equity ratio of 0.01. STAAR Surgical has a fifty-two week low of $8.95 and a fifty-two week high of $17.60. The company has a market capitalization of $664.76, a price-to-earnings ratio of -388.75 and a beta of 1.22.
Several institutional investors and hedge funds have recently modified their holdings of the stock. MetLife Investment Advisors LLC bought a new stake in shares of STAAR Surgical in the fourth quarter worth $301,000. Macquarie Group Ltd. grew its holdings in shares of STAAR Surgical by 138.2% in the fourth quarter. Macquarie Group Ltd. now owns 17,630 shares of the medical instruments supplier’s stock worth $273,000 after acquiring an additional 10,230 shares during the period. Millennium Management LLC bought a new stake in shares of STAAR Surgical in the fourth quarter worth $7,153,000. Meadow Creek Investment Management LLC grew its holdings in shares of STAAR Surgical by 21.9% in the fourth quarter. Meadow Creek Investment Management LLC now owns 81,816 shares of the medical instruments supplier’s stock worth $1,268,000 after acquiring an additional 14,672 shares during the period. Finally, Two Sigma Investments LP grew its holdings in shares of STAAR Surgical by 113.8% in the fourth quarter. Two Sigma Investments LP now owns 163,103 shares of the medical instruments supplier’s stock worth $2,528,000 after acquiring an additional 86,831 shares during the period. 78.95% of the stock is owned by institutional investors.
A number of analysts have commented on STAA shares. BidaskClub lowered STAAR Surgical from a “sell” rating to a “strong sell” rating in a report on Saturday, January 6th. Zacks Investment Research lowered STAAR Surgical from a “hold” rating to a “sell” rating in a report on Wednesday, March 14th. One investment analyst has rated the stock with a sell rating and three have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $17.67.
ILLEGAL ACTIVITY NOTICE: “Insider Selling: STAAR Surgical (STAA) CTO Sells 2,188 Shares of Stock” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3296731/insider-selling-staar-surgical-staa-cto-sells-2188-shares-of-stock.html.
About STAAR Surgical
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.
Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.